Zimmer Holdings, Inc.  

(Public, NYSE:ZMH)   Watch this stock  
Find more results for Dental One, Inc.�
113.09
-0.68 (-0.60%)
May 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 112.71 - 113.79
52 week 94.73 - 121.84
Open 113.79
Vol / Avg. 0.00/1.17M
Mkt cap 19.34B
P/E 28.78
Div/yield 0.22/0.78
EPS 3.93
Shares 170.40M
Beta 0.93
Inst. own 88%
Jul 22, 2015
Q2 2015 Zimmer Holdings Inc Earnings Release (Estimated) - 7:00AM EDT - Add to calendar
May 13, 2015
Zimmer Holdings Inc at Bank of America Merrill Lynch Health Care Conference
May 5, 2015
Zimmer Holdings Inc Annual Shareholders Meeting
Apr 30, 2015
Q1 2015 Zimmer Holdings Inc Earnings Call
Apr 30, 2015
Q1 2015 Zimmer Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 15.59% 15.39%
Operating margin 24.23% 22.14%
EBITD margin - 37.81%
Return on average assets 5.29% 7.48%
Return on average equity 10.84% 11.24%
Employees 10,000 -
CDP Score - 58 E

Address

345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company also provides other healthcare related services. The Company’s customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories. The Company’s products include orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
James T. Crines Executive Vice President - Finance, Chief Financial Officer
Age: 55
Bio & Compensation  - Reuters
Joseph A. Cucolo President, Americas
Age: 55
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 51
Bio & Compensation  - Reuters
Stephen H. L. Ooi President, Asia Pacific
Age: 61
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Derek M. Davis Vice President - Finance, Corporate Controller, Chief Accounting Officer
Age: 46
Bio & Compensation  - Reuters
Larry C. Glasscock Independent Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Michael J. Farrell Director
Age: 42
Bio & Compensation  - Reuters
Christopher B. Begley Independent Director
Age: 62
Bio & Compensation  - Reuters